SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549 ----------- FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 November 27, 2000 Date of Report (Date of earliest event reported) PE CORPORATION (Exact Name of Registrant as Specified In Charter) Delaware 1-4389 06-1534213 (State or Other Jurisdiction (Commission (IRS Employer of Incorporation) File No.) Identification No.) 761 Main Avenue Norwalk, Connecticut 06859-0001 (Address of Principal Executive Offices, Including Zip Code) (203) 762-1000 (Registrant's telephone number, including area code) Item 5. Other Items. On November 27, 2000, PE Corporation (the "Company") announced that it will change the Company's corporate name to Applera Corporation and the name of the Company's PE Biosystems Group to the Applied Biosystems Group, effective November 30, 2000 (the "Name Changes"). In connection with the Name Changes, the stock symbol for the Applera Corporation - Applied Biosystems Group Common Stock on the New York Stock Exchange will change from "PEB" to "ABI," effective November 30, 2000. The stock symbol for the Applera Corporation - Celera Genomics Group Common Stock will remain "CRA." The Company will also change its web address to www.applera.com from www.pecorporation.com, effective November 30, 2000. Certificates which prior to the Name Changes represented shares of PE Corporation - PE Biosystems Group Common Stock will after the Name Changes represent shares of Applera Corporation - Applied Biosystems Group Common Stock, and certificates which prior to the Name Changes represented shares of PE Corporation - Celera Genomics Group Common Stock will after the Name Changes represent shares of Applera Corporation - Celera Genomics Group Common Stock. The Name Changes were announced and further described in a press release issued by the Company on November 27, 2000, a copy of which is filed as Exhibit 99 to this Report and is incorporated by reference into this Item 5. Item 7. Financial Statements, Pro Forma Financial Information and Exhibits. (c) Exhibits. The following exhibit is filed with this Report: Exhibit No. Description 99 Press Release of the Company issued November 27, 2000. SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. PE CORPORATION By: /s/ Thomas P. Livingston ---------------------------- Thomas P. Livingston Secretary Dated: November 27, 2000 EXHIBIT INDEX Exhibit No. Description 99 Press Release of the Company issued November 27, 2000.
News Release Applera Corporation 50 Danbury Rd. Norwalk, Conn. U.S.A. 06859 Applied Biosystems 850 Lincoln Centre Drive Contacts: Foster City, CA 94404 T (650) 570-6667 Media Investors Celera Genomics ----- --------- 45 West Gude Drive Jay Rhodes Charles Poole Rockville, MD 20850 650.554.2581 240.453.3620 T (240) 453-3000 For Immediate Release PE CORPORATION TO CHANGE NAME TO APPLERA CORPORATION PE Biosystems Group Name Also to Change to Applied Biosystems Group and NYSE Stock Symbol to Change to ABI NORWALK, CT - November 27, 2000 - PE Corporation announced today that the previously-announced name change to Applera Corporation will become effective on Thursday, November 30, 2000. This new name is a combination of the names of the company's two operating businesses, the Applied Biosystems Group and the Celera Genomics Group. The PE Biosystems Group name change to the Applied Biosystems Group will also become effective on November 30, and its stock symbol on the New York Stock Exchange (NYSE) will change from PEB to ABI at the opening of trading on that date. The NYSE symbol for the Celera Genomics Group will remain CRA. Applera Corporation will change its web address from www.pecorporation.com to www.applera.com effective November 30. "This name symbolizes our company's evolution as a life sciences company with a mission to improve the human condition," said Tony L. White, chairman, president and chief executive officer of the company. "The new name reflects the complementary role of our business groups in providing tools and information to academic, biotechnology and pharmaceutical researchers. I am especially pleased by the brand recognition achieved by Applied Biosystems and Celera Genomics. Customers have identified these names with high quality DNA and protein analysis systems and information to drive discovery. We also intend to capitalize on the synergies of the groups in pursuing the molecular diagnostics initiative announced November 6." Background In 1993, The Perkin-Elmer Corporation of Norwalk, CT, merged with Applied Biosystems, Inc., which was founded in Foster City, CA, in 1981. In 1998, Perkin-Elmer consolidated its premier life science technologies into the PE Biosystems division, consisting of Applied Biosystems, PerSeptive Biosystems, Tropix and PE Informatics. The company had acquired PerSeptive Biosystems, a company focused on the analysis of proteins, in 1998 and Tropix, Inc., a chemiluminescence company, in 1996. Informatics was formed by combining two acquired entities, Molecular Informatics and Nelson Analytical Systems, with existing units of Perkin-Elmer. In order to focus its mission on the life sciences, the company was recapitalized under the name PE Corporation in 1999. As part of the recapitalization, the company established two new classes of common stock that track the Applied Biosystems Group and the Celera Genomics Group. The company also sold its analytical instruments division and the Perkin-Elmer name, which was most closely associated with that business. At the company's annual meeting on October 19, 2000, stockholders approved the name changes from PE Corporation to Applera Corporation and from the PE Biosystems Group to the Applied Biosystems Group. PE Corporation comprises two operating groups. The Applied Biosystems Group develops and markets instrument-based systems, reagents, software and contract services to the life science industry and research community. Customers use these tools to analyze nucleic acids (DNA and RNA), small molecules and proteins in order to make scientific discoveries, develop new pharmaceuticals and conduct standardized testing. Applied Biosystems is headquartered in Foster City, CA, and reported sales of $1.4 billion during fiscal 2000. The Celera Genomics Group, headquartered in Rockville, MD, intends to become the definitive source of genomic and related medical information. Information about the company, including reports and other information filed by the company with the Securities and Exchange Commission, is available on the worldwide web. The address will change from www.pecorporation.com to www.applera.com effective November 30. Information is also available by telephoning 800.762.6923. Copyright (C) 2000. PE Corporation. All Rights Reserved. PE, Applera, Celera, and Celera Genomics are trademarks and Applied Biosystems, PerSeptive, and Tropix are registered trademarks of PE Corporation or its subsidiaries in the US and certain other countries.